# Xiaohua Huang

> Xiaohua Huang is a Series C investor at China Merchants Venture Capital backing Medical. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [China Merchants Venture Capital](https://shizune.co/investors/profile/china-merchants-capital)
- Location: Shenzhen, China
- Total investments: 2
- Last investment: Feb 2024
- Lead investor: 50%
- Last updated: Aug 2026

Xiaohua Huang is a Series C investor at China Merchants Venture Capital in Shenzhen focused on Medical and Health Care. Xiaohua Huang currently serves as CFO of China Merchants Capital.Prior to joining CMC, he was director of finance department of China Merchants Group, vice director of Finance department of China Merchants Holdings International, CFO of Shenzhen Magang Depot & Port, and CFO as well as Secretary of the Board of Zhanjiang Port Group. XiaohuaHuang has participated in audit, consulting and tax planning for a number of listed companies such as Bank of China, China Merchants Bank and Yantian Port.Xiaohua Huang holds a master’s degree in Management and a bachelor’s degree in Accounting & Auditing from Sun Yat-sen University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |
| Manufacturing | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 1 | 50% |
| Private Equity | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MingDu Intelligent | MingDu Intelligent is a medical intelligent manufacturing service provider. |  | Series C | Feb 29, 2024 |  |
| PegBio | Founded in 2008, Suzhou city-based PegBio is a bio-pharmaceutical company specializing in the development of innovative drugs to combat diabetes and obesity. Its key product PB-119, an agonist of glucagon-like peptide 1 (GLP-1), allows diabetes patients to take medicine once a week, instead of requiring daily injections. | $122M | Private Equity | Dec 02, 2020 |  |

2 of 2 investments shown.

## Co-investors
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 1 deal together
- [Qianhai Fund of Funds](https://shizune.co/investors/profile/qianhai-fund-of-funds) — VC Fund, 1 deal together
- [Shenzhen Capital Group](https://shizune.co/investors/profile/shenzhen-capital-group) — VC Fund, 1 deal together
- [Yingke Capital](https://shizune.co/investors/profile/yingke-capital) — VC Fund, 1 deal together

## About China Merchants Venture Capital

VC Fund · Shenzhen, China

China Merchants Capital is engaged in alternative investment and asset management.

5 contacts available at China Merchants Venture Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Rizhong Zhang | CEO | https://shizune.co/investors/profile/rizhong-zhang |
| Xiaohua Huang | Chief Financial Officer | https://shizune.co/investors/profile/xiaohua-huang |
| Jian Guo | COO, General Manager | https://shizune.co/investors/profile/jian-guo-dbcd |
| Jianhong Li | Chairman | https://shizune.co/investors/profile/jianhong-li |
| Liming Yu | Director | https://shizune.co/investors/profile/liming-yu |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Xiaohua Huang invest in?

Xiaohua Huang invests primarily in Medical, Health Care and Manufacturing startups, most often at Series C and Private Equity stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Xiaohua Huang last invest?

The most recent investment recorded for Xiaohua Huang closed in Feb 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co